Phospho-p38 MAPK Expression in COPD Patients and Asthmatics and in Challenged Bronchial Epithelium
Authors:
- Fabio L.M. RicciardoloFRFabio L.M. Ricciardolo
- Isabella GnemmiIGIsabella Gnemmi
- Paolo CasolariPCPaolo Casolari
- Paola BrunPBPaola Brun
- Valentina SorbelloVSValentina Sorbello
- Armando CapelliACArmando Capelli
- Francesco CappelloFrancesco Cappello
- Giorgio Narciso CavallescoGCGiorgio Narciso Cavallesco
- Alberto PapiAPAlberto Papi
- Kian Fan ChungKCKian Fan Chung
- Bruno BalbiBBBruno Balbi
- 14 March 2015
- journal article
- research article
- Published by S. Karger AG in Respiration
- Vol. 89 (4) , 329-342
Abstract
Background: The role of mitogen-activated protein kinases (MAPK) in regulating the inflammatory response in the airways of patients with chronic obstructive pulmonary disease (COPD) and asthmatic patients is unclear. Objectives: To investigate the expression of activated MAPK in lungs of COPD patients and in bronchial biopsies of asthmatic patients and to study MAPK expression in bronchial epithelial cells in response to oxidative and inflammatory stimuli. Methods: Immunohistochemical expression of phospho (p)-p38 MAPK, p-JNK1 and p-ERK1/2 was measured in bronchial mucosa in patients with mild/moderate (n = 17), severe/very severe (n = 16) stable COPD, control smokers (n = 16), control non-smokers (n = 9), in mild asthma (n = 9) and in peripheral airways from COPD patients (n = 15) and control smokers (n = 15). Interleukin (IL)-8 and MAPK mRNA was measured in stimulated 16HBE cells. Results: No significant differences in p-p38 MAPK, p-JNK or p-ERK1/2 expression were seen in bronchial biopsies and peripheral airways between COPD and control subjects. Asthmatics showed increased submucosal p-p38 MAPK expression compared to COPD patients (p < 0.003) and control non-smokers (p < 0.05). Hydrogen peroxide (H2O2), cytomix (tumour necrosis factor-α + IL-1β + interferon-γ) and lipopolysaccharide (LPS) upregulated IL-8 mRNA at 1 or 2 h. p38 MAPKα mRNA was significantly increased after H2O2 and LPS treatment. JNK1 and ERK1 mRNA were unchanged after H2O2, cytomix or LPS treatments. Conclusion: p-p38 MAPK expression is similar in stable COPD and control subjects but increased in the bronchi of mild asthmatics compared to stable COPD patients. p38 MAPK mRNA is increased after bronchial epithelial challenges in vitro. These data together suggest a potential role for this MAPK in Th2 inflammation and possibly during COPD exacerbations.Keywords
This publication has 35 references indexed in Scilit:
- Regulation of Wnt4 in chronic obstructive pulmonary diseaseThe FASEB Journal, 2013
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2013
- Mapping the Transcriptional Machinery of the IL-8 Gene in Human Bronchial Epithelial CellsThe Journal of Immunology, 2011
- Oxidative Stress–induced Antibodies to Carbonyl-modified Protein Correlate with Severity of Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2011
- The tyrosine phosphatase, SHP-1, is involved in bronchial mucin production during oxidative stressBiochemical and Biophysical Research Communications, 2010
- Association of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPDThorax, 2009
- Increased activation of p38 MAPK in COPDEuropean Respiratory Journal, 2007
- Increased expression of p38 MAPK in human bronchial epithelium after lipopolysaccharide exposureEuropean Respiratory Journal, 2005
- Exposure of Differentiated Airway Epithelial Cells to Volatile Smoke in vitroRespiration, 2004
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001